Printer Friendly

FMPI PROJECTS PROFIT FOR FIRST QUARTER ENDING AUG. 30, 1992

 FMPI PROJECTS PROFIT FOR FIRST QUARTER ENDING AUG. 30, 1992
 HAUPPAUGE, N.Y., July 22 /PRNewswire/ -- Future Medical Products, Inc. (NASDAQ: FMPI) announced today that it has sold half of its 51 percent stock interest in Elemedical (UK) for $1 million resulting in a net profit of approximately $975,000. Based on this transaction, the company anticipates reporting its first profitable quarterly results.
 Steven Cantor, president, stated, "The company's reduction of its holdings in Elemedical (UK) was based upon a decision to utilize the profits to speed the introduction of our non-invasive coronary artery treatment device (EECP)."
 Future Medical Products, Inc. is a medical technology company involved in the research, development and distribution of health care products.
 -0- 7/22/92
 /CONTACT: Herb Glicksman of Future Medical Products, 516-348-0500/
 (FMPI) CO: Future Medical Products Inc. ST: New York IN: MTC SU: ERP


SM-TQ -- NY011 -- 1690 07/22/92 08:38 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 22, 1992
Words:151
Previous Article:DATA GENERAL REPORTS THIRD QUARTER RESULTS
Next Article:MEDIA BRIEFING: NEUROSCIENTIST DISCOVERS MOLECULAR MECHANISMS OF COCAINE ADDICTION AND SCHIZOPHRENIA
Topics:


Related Articles
ANNOUNCES FIRST QUARTER RESULTS THE CONTINUUM COMPANY, INC.
FMPI ANNOUNCES ORDER OF 27 EECP TREATMENT DEVICES TO OPEN FIRST OF 12 PLANNED CLINICS
BOWMAR INSTRUMENT CORP. ANNOUNCES THIRD QUARTER RESULTS FOR PERIOD ENDED JUNE 30, 1992, AND EXCHANGE OFFER
THERAGENICS ACHIEVES RECORD SECOND QUARTER RESULTS; SUCCESS OF CANCER THERAPY PRODUCT BOOSTS QUARTERLY REVENUE 121 PERCENT
FUTURE MEDICAL PRODUCTS REPORTS FIRST QUARTER RESULTS
FUTURE MEDICAL PRODUCTS, INC. APPOINTS FREDERIC D. HELLER AS CHIEF FINANCIAL OFFICER; GRANT THORNTON SELECTED AS INDEPENDENT AUDITORS
FUTURE MEDICAL PRODUCTS, INC. APPOINTS FREDERIC D. HELLER AS CHIEF FINANCIAL OFFICER; GRANT THORNTON SELECTED AS INDEPENDENT AUDITORS
EV ENVIRONMENTAL REPORTS SECOND QUARTER RESULTS
PIEMONTE FOODS, INC. ANNOUNCES HIGHER FIRST QUARTER RESULTS
THE KEITH GROUP REPORTS FINANCIAL RESULTS FOR TWELVE MONTH PERIOD ENDING AUG. 31, 1993 AND THREE MONTH PERIOD ENDING NOV. 30, 1993

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters